Tectonic Therapeutic (TECX) Treasury Shares (2017 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Treasury Shares of $479042.0 for Q1 2026, up 163.23% year-over-year from $181987.0 in Q1 2025, and up 82.71% quarter-over-quarter from $262184.0 in Q4 2025.
Tectonic Therapeutic (TECX) Treasury Shares (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Treasury Shares for 10 consecutive years, with $479042.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Treasury Shares rose 163.23% year-over-year to $479042.0; the TTM figure through Mar 2026 stood at $479042.0 (up 163.23% YoY), while the FY2025 annual figure was $262184.0, up 923.68% from the prior year.
- Treasury Shares grew to $479042.0 in Q1 2026 per TECX's latest filing, from $262184.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $3.6 million in Q4 2023 and bottomed at $6859.0 in Q3 2024.
- Historically, Treasury Shares has averaged $891583.2 across 5 years, with a median of $774160.5 in 2022.
- Annual changes were most pronounced in 2022 — Treasury Shares surged 87089.86% — and 2024, when it tumbled 99.44%.
- Tectonic Therapeutic's Treasury Shares stood at $940392.0 in 2022, then surged by 287.89% to $3.6 million in 2023, then plunged by 99.81% to $6859.0 in 2024, then jumped by 3722.48% to $262184.0 in 2025, then soared by 82.71% to $479042.0 in 2026.
- Business Quant data shows TECX's Treasury Shares at $479042.0 in Q1 2026, $262184.0 in Q4 2025, and $256325.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Tectonic Therapeutic | 671.50 Mn | 671.50 Mn | - | 484,320.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 484,320.00 |
| Jun 30, 2026 | 484,320.00 |
| Mar 31, 2026 | 479,042.00 |
| Mar 31, 2026 | 479,042.00 |
| Dec 31, 2025 | 262,184.00 |
| Dec 31, 2025 | 262,184.00 |
| Sep 30, 2025 | 256,325.00 |
| Sep 30, 2025 | 256,325.00 |
| Jun 30, 2025 | 193,628.00 |
| Jun 30, 2025 | 193,628.00 |
| Mar 31, 2025 | 181,987.00 |
| Mar 31, 2025 | 181,987.00 |
| Sep 30, 2024 | 6,859.00 |
| Sep 30, 2024 | 6,859.00 |
| Jun 30, 2024 | 11,447.00 |
| Jun 30, 2024 | 11,447.00 |
| Mar 31, 2024 | 677,785.00 |
| Mar 31, 2024 | 677,785.00 |
| Dec 31, 2023 | 3.65 Mn |
| Dec 31, 2023 | 3.65 Mn |